Triscend: 6-Month Outcomes Of Transfemoral Tvr In Patients With Tricuspid Regurgitation

TRISCEND: 6-Month Outcomes of Transfemoral TVR in Patients With Tricuspid Regurgitation

PCR

TCT 2021: TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients | Dr Susheel Kodali

Transfemoral Tricuspid Valve Replacement In Patients With Tricuspid Regurgitation-30-day Results Of

HPR

TRISCEND II: Transcatheter tricuspid valve replacement in patients with severe TR

PCR

Transcatheter tricuspid valve replacement

Johnson Francis, MBBS, MD, DM

ACC 21: 30-day Results of the TRISCEND Study

TRILUMINATE: Qol after transcatheter tricuspid-valve repair vs. medical therapy in severe TR

PCR

The once forgotten valve: Emerging treatments for tricuspid regurgitation. Dr Grant Kim. CedarsSinai

Yale Interventional Cardiology

The Two Minute Article CVS Series – Outcomes of Tricuspid Valve Surgery in Patients Functional TR

Tricuspid Regurgitation: Underdiagnosed and Undertreated

Medtronic Cardiac and Vascular

Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from TriClip bRIGHT

PCR

Transfemoral Transcatheter Tricuspid Valve Replacement (TTVR) | Prof David Muller

St Vincent’s Hospital, Sydney

Evoque Tricuspid Intervention:Jubin Joseph, MD

St. Francis Hospital & Heart Center

View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up

Tricuspid Regurgitation Therapy Retreat TR2 The State of the Field

Cardiovascular Innovations

Looking into the treatment of TR with the Edwards portfolio - EuroPCR 2021

PCR

Transcatheter Trilogy Part 3: Edwards’ portfolio of tricuspid treatment options | Presentation

Edwards Lifesciences Mitral & Tricuspid Therapy EU

Planning and Results of Transcatheter Tricuspid Valve Therapy - Dr. Didier Tchètchè

New York Transcatheter Valves

Tricuspid Valve Disease Treatment—Surgical or Transcatheter?, November 18, 2021

ThoracicSurgeons

[TCAP 2022] Structural Heart Disease Live Case Session 5: Transcatheter Tricuspid Valve Replacement